RAZADYNE ER
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
Apr 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RAZADYNE ER is an extended-release oral capsule small molecule approved in 2005 for treating Alzheimer's disease and related cognitive disorders. The drug mechanism of action and specific indication details are not provided in available data. Patients taking this medication typically have mild to moderate cognitive impairment requiring chronic oral therapy.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30), signaling potential team restructuring or focus on market defense rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and approaching LOE, career opportunities on RAZADYNE ER are limited and focused on protecting market share through commercialization efficiency. Professionals should expect roles centered on competitive defense, patient retention, and cost optimization rather than growth initiatives.
Brand ManagerMedical Science Liaison
Worked on RAZADYNE ER at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.